As war rages and Trump looms, a recent Denmark election featured little mention of the ailing $164 billion drugmaker Novo Nordisk. In this Viewsroom podcast, Breakingviews columnists discuss the future of weight‑loss pills and Novo’s place in it reut.rs/4sEpCUg
— Reuters (@Reuters) Mar 29, 2026
The post 🔊 As war rages and Trump looms, a recent Denmark election featured little mention of the ailing $164 billion drugmaker Novo Nordisk. In this Viewsroom podcast, Breakingviews columnists discuss the future of weight‑loss pills and Novo’s place in it https://reut.rs/4sEpCUg first appeared on October Surprise 2016 – octobersurprise2016.org.
